Influence of Age and Cytochrome P450 2C9 Genotype on the Steady-State Disposition of Diclofenac and Celecoxib
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 42 (3) , 283-292
- https://doi.org/10.2165/00003088-200342030-00003
Abstract
Objective To analyse the influence of age and cytochrome P450 (CYP) 2C9 genotype on the steady-state disposition of the standard NSAID diclofenac and the new COX-2 selective inhibitor celecoxib, both...Keywords
This publication has 49 references indexed in Scilit:
- Measures of Exposure versus Measures of Rate and Extent of AbsorptionClinical Pharmacokinetics, 2001
- COX-2 Selective Nonsteroidal Anti-Inflammatory DrugsDrugs, 2000
- Clinical Pharmacokinetics and Pharmacodynamics of CelecoxibClinical Pharmacokinetics, 2000
- Validation of Methods for CYP2C9 Genotyping: Frequencies of Mutant Alleles in a Swedish PopulationBiochemical and Biophysical Research Communications, 1999
- The Aging LiverClinical Pharmacokinetics, 1998
- Drug Dosage in the ElderlyDrugs & Aging, 1998
- Cytochrome P450TB (CYP2C): A major monooxygenase catalyzing diclofenac 4′-hydroxylation in human liverLife Sciences, 1993
- Methods of Determining Plasma and Tissue Binding of DrugsClinical Pharmacokinetics, 1992
- The Pharmacokinetics of Non-Steroidal Anti-Inflammatory Drugs in the ElderlyClinical Pharmacokinetics, 1987
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976